Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.31 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.31 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16401124 | 0.90 | L3MBTL1 (0.34) | P2RY1L3MBTL1SMN1; SMN2SLC5A1SLC5A2 | |
| SCHEMBL16400833 | 0.90 | P2RY1 (0.34) | P2RY1BCHEACHEBACE1SMN1; SMN2 | |
| SCHEMBL16400845 | 0.88 | L3MBTL1 (0.34) | P2RY1L3MBTL1SMN1; SMN2MAPTSLC5A1 | |
| SCHEMBL16401006 | 0.85 | BCHE (0.37) | P2RY1L3MBTL1BCHEACHEBACE1 | |
| SCHEMBL16401004 | 0.85 | BCHE (0.37) | P2RY1L3MBTL1BCHEACHEBACE1 | |
| SCHEMBL19304575 | 0.85 | L3MBTL1 (0.34) | P2RY1L3MBTL1SLC5A1SLC5A2 | |
| SCHEMBL16401852 | 0.83 | GCGR (0.34) | P2RY1L3MBTL1SMN1; SMN2 | |
| SCHEMBL16400863 | 0.82 | CHRNA7 (0.39) | P2RY1L3MBTL1 | |
| SCHEMBL17798961 | 0.81 | NPC1 (0.34) | P2RY1BCHEACHEBACE1SMN1; SMN2 | |
| SCHEMBL16401265 | 0.81 | PPARD (0.34) | P2RY1SMN1; SMN2MAPTGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3022185-B1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2017-09-06 | — | — | EP | claimed |
| US-9497970-B2 | Pesticide compounds | BASF SE (DE) | 2016-11-22 | — | — | US | claimed |
| US-20160157491-A1 | Pesticide Compounds | BASF SE (DE) | 2016-06-09 | — | — | US | claimed |
| EP-3022185-A1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2016-05-25 | — | — | EP | claimed |
| WO-2015007682-A1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2015-01-22 | — | — | WO | claimed |
| EP-3022185-B1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2017-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160157491-A1 | Pesticide Compounds | C1R, C1S, CBR3 | P2RY1 1306/4885L3MBTL1 705/4885BCHE 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.